Zeer OneOncology / intent / oneoncology

OneOncology

1001-5000 employees·Nashville, Tennessee, United States·oneoncology.com

Observed, not inferred · updated weekly

Buying intent

14 tracked signals | Top 12 topics are below | Engineering is carrying most of it.

14signals · 30 days
12topics tracked
50%attributed to a team

Attention by team

LinkedIn activity, by team

Where OneOncology's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.

Clinical Trials
Artificial Intelligence
Third-Party Access
Enterprise Security
Healthcare cost management
Power BI
Engineering
Engineering to Clinical Trials: no signal
High50% of team Engineering to Artificial Intelligence: High, 50% of this team's signals
Medium25% of team Engineering to Third-Party Access: Medium, 25% of this team's signals
Medium25% of team Engineering to Enterprise Security: Medium, 25% of this team's signals
Engineering to Healthcare cost management: no signal
Engineering to Power BI: no signal
Others
High50% of team Others to Clinical Trials: High, 50% of this team's signals
Others to Artificial Intelligence: no signal
Others to Third-Party Access: no signal
Others to Enterprise Security: no signal
Medium25% of team Others to Healthcare cost management: Medium, 25% of this team's signals
Medium25% of team Others to Power BI: Medium, 25% of this team's signals
LowMediumHigh·  banded against the busiest pairing on this page

Topics being researched

30-day window

Every tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.

Clinical Trials
LinkedIn
High volume
97%
last
10d ago
Artificial Intelligence
LinkedIn
High volume
96%
last
16d ago
Third-Party Access
LinkedIn
Medium volume
98%
last
29d ago
Enterprise Security
LinkedIn
Medium volume
96%
last
29d ago
Healthcare cost management
LinkedIn
Medium volume
98%
last
28d ago
Power BI
LinkedIn
Medium volume
98%
last
9d ago
AI Agent Software
LinkedIn
Medium volume
92%
last
19d ago
Agentic AI System
LinkedIn
Medium volume
94%
last
19d ago
Deleted file
LinkedIn
Medium volume
98%
last
22d ago
Data Analytics
LinkedIn
Medium volume
96%
last
9d ago
Digital Transformation
LinkedIn
Medium volume
96%
last
9d ago
Next.js
LinkedIn
Medium volume
92%
last
9d ago

Need intent for a specific topic or industry?

We track the full taxonomy across every account in the graph — including themes not shown on this page.

Talk to us

Who's active at OneOncology

verified title on file

Titles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.

Others3 active
researching Digital Transformation
in
VPresearching Healthcare cost management
in
Directorresearching Clinical Trials
in
Engineering1 active
researching Artificial Intelligence
in

Primary products / business lines

LinkedIn company profile

OneOncology was founded by community physicians, for community physicians, with the mission of improving the lives of everyone living with cancer and other diseases. Our goal is to enable community medical practices to remain independent and to improve patient access to care in their communities, all at a lower cost than in the hospital setting. OneOncology supports our platform of community medic

Top accounts researching OneOncology

names withheld on the public page

These are companies whose own people brought up OneOncology unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.

3,463 companies · 13,523 people are researching Clinical Trials

OneOncology's own team shows 2 signals on this topic. No one outside OneOncology has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.

  • Artificial Intelligence129,094 cos · 649,540 people
  • Third-Party Access68 cos · 138 people
Sign up to see which companies →

Buyer profile

company size · seniority

Company size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.

Unlock the buyer profile

Company-size breakdown and buyer seniority mix for accounts researching OneOncology.

Company size breakdown
Buyer seniority mix

Sign up to learn more

Create an account to explore buyer insights as they become available.

Sign up to learn more →

Buying committee functions

Employee job titles (LinkedIn)

Engineering — 1 person; Leadership — 1 person

What's been said

public posts by OneOncology's team

No public post naming OneOncology has surfaced in the past year, so this is what OneOncology's own team is posting about publicly — their topics, in their words.

LinkedIn

This is why we need 340B reform and accountability.

May 2026
LinkedIn

Andie Schilstra is #hiring . Know anyone who might be interested?

May 2026
LinkedIn

The Caregiver Is Often the Real Customer in Healthcare AI Every consumer healthcare AI deck I’ve seen in the last six months centers the patient. The patient asks questions. The patient gets summaries. The patient tracks symptoms. The pricing models, the engagement metrics, the user research — all aimed at the person with the diagnosis. This misreads the actual buying decision in chronic disease. The daughter managing her mother’s chemo calendar is the engaged user. The spouse weighing the CHF patient every morning and titrating diuretics is the engaged user. The adult child coordinating three specialists, two pharmacies, and a Medicare Advantage plan for a parent with dementia is the engaged user. They are also disproportionately the ones with disposable income, smartphone fluency, and a willingness to pay for relief. Patients in active treatment are exhausted. Caregivers are activated. The numbers tell the story. AARP estimates 48 million unpaid family caregivers in the US providing care worth roughly $600 billion annually. The average caregiver spends 26% of personal income on care-related expenses. Sixty-one percent are women. Most are juggling caregiving with full-time work. They are searching, scheduling, advocating, and decision-making on behalf of someone whose cognitive bandwidth is consumed by illness. This audience has specific, unmet needs that current consumer healthcare AI does not address: • Multi-patient context. One account, mom and dad’s records, separate care plans, shared escalation logic. • Asynchronous communication. The caregiver needs to ask at 11pm what the oncologist said at 2pm. • Decision support framed for non-clinicians. Not “your creatinine is elevated” but “this lab result usually means your father needs more fluids; here’s when to call the doctor.” • Care coordination artifacts. Visit summaries the caregiver can forward to a sibling, a home health aide, or the next specialist. • Permission and identity layers. HIPAA-aware proxy access, not a shared password. Consumer health AI built around the patient defaults to a single-user, single-condition, English-fluent, digitally-native, in-treatment model. That is not the chronic disease market. That is a sliver of it. The caregiver economy is the larger willingness-to-pay segment. It is also the segment most likely to convert engagement into retention, because the work does not end when the patient feels better. It ends when the patient dies. Build for the daughter. The patient gets served as a consequence. #HealthcareAI #Caregivers #ChronicDisease #DigitalHealth #FamilyCaregiving

May 2026
LinkedInArtificial Intelligence

Five things I’ve built with AI lately — some at work, some personal Yes, I use it to write emails, analyze documents, and answer questions I’d otherwise have to Google for an hour. But the most fun I’ve had with AI lately is actually building things with it. Here’s what my team and I have put together recently: 1. Automated a manual data entry process at work Simple tool, self-contained — but it eliminated a genuinely tedious step for real people on our team working with regulatory documents. Sometimes that’s enough. 2. A data migration tool between two platforms we use every day Yes, a standard import tool exists. But this one pulls and maps the data for me and flags when values don’t translate correctly. Runs locally, works well, and saves my eyes and my sanity on large detailed datasets. 3. A training and access prototype Always deprioritized because the ROI was hard to justify. AI made it cheap enough to stop waiting and just try. Pretty confident it’s going to be a big win for our sites. 4. A Claude branding skill for Hometeam Pizza A reusable AI setup that knows our voice and vibe. Creating content and generating ideas is so much easier with this as a starting point. 5. A recipe sharing app for my family Meal planning, AI-generated recipes, a comment thread for swapping tweaks. A fun project I’m learning from that also helps me personally. That’s enough for me. I don’t think AI is replacing software teams. But I do think it’s going to compress timelines, help people actually communicate what they need, and — maybe most importantly — finally give teams a way to build the tools that are always important but never urgent enough to prioritize. That last one is where I think the real opportunity is. The backlog of good ideas that never got resourced is about to get a lot shorter.

Apr 2026
LinkedInOpen Source

It's not perfect but I've been building a slick workflow for my agents. Human in the loop is important but how do you condense the amount of time a human needs to be in the loop and has the highest leverage in that loop? I call it Human Approving the loop. Or Human ON the loop. Not in it. The loop runs without me. My primary goals have been: 1. Reduce cognitive functions needed to review massive amounts of inbound data. 2. Remove decision processing and routing of incoming new information. 3. Producing artifacts from new information. 4. Taking action on those artifacts. 5. A reinforcement loop that get's better over time. I own all of this 100%. If Obsidian, Claude, Codex blow up tomorrow, I own all the knowledge, data, structure, workflows, etc., and I can use open source models. Literally any model can pitch in to build my wiki.

Apr 2026

About this data. OneOncology (oneoncology.com). Department attribution is 50%; remaining activity is grouped under Others. Updated 2026-09-25T18:00:10.181Z.

Not yet computedPer-team narrative summaries